Company Overview and News

 
New Pacific Reports Financial Results for the Three and Nine Months Ended March 31, 2018

2018-05-18 globenewswire
VANCOUVER, British Columbia, May 18, 2018 (GLOBE NEWSWIRE) -- New Pacific Metals Corp. (TSX-V:NUAG) (OTCQX:NUPMF) (“New Pacific” or the “Company”) today announced its unaudited condensed consolidated interim financial results for the three and nine months ended March 31, 2018.

 
Silvercorp Metals: Deep Value With Strong Fundamentals

2018-05-16 seekingalpha
Silvercorp Metals is deeply undervalued with no long-term debt and lots of cash. It is the cheapest among its peers.

 
BRIEF-New Pacific Qtrly Loss Per Share $0.01

2018-02-15 reuters
* NEW PACIFIC REPORTS FINANCIAL RESULTS FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2017

1
Top 5 Silver Stocks For 2018

2018-01-03 seekingalpha
2017 was a pretty tough year for silver stocks in general, and I admit that my top picks have not done very well.

 
BRIEF-New Pacific Metals Increased Directors On Board From Five To Six

2017-11-29 reuters
* NEW PACIFIC METALS REPORTS 2017 AGM RESULTS AND ANNOUNCES APPOINTMENT OF PAN AMERICAN SILVER DIRECTOR NOMINEE

 
BRIEF-New Pacific reports results for three months ended September

2017-11-17 reuters
* New Pacific Metals Corp - ‍for three months ended September 30, 2017, net loss attributable to equity holders was $0.01 per share​ Source text for Eikon: Further company coverage:

 
New Pacific Metals Corp. Appoints New President

2017-08-16 marketwired
New Pacific Metals Corp. ("New Pacific" or the "Company") (TSX VENTURE:NUAG) is pleased to announce the appointment of Gordon Neal to the position of President of the Company. Mr. Neal has extensive experience in the metals and mining sector, capital markets and government communications. He was most recently the Vice President of Corporate Development for Silvercorp Metals Inc., New Pacific's largest shareholder.

 
New Pacific Metals Corp. Appoints John McCluskey as new Director and Grants Stock Options

2017-08-01 marketwired
New Pacific Metals Corp. ("New Pacific" or the "Company") (TSX VENTURE:NUAG) is pleased to announce the appointment of John McCluskey to its Board of Directors.

 
New Pacific Announces Closing of Private Placement

2017-07-28 marketwired
New Pacific Metals Corp. ("New Pacific" or the "Company") (TSX VENTURE:NUAG) is pleased to announce that it has closed its previously announced private placement (the "Private Placement") of 1,250,000 common shares (the "Shares") at a price of US$0.80 per Share for gross proceeds of US$1,000,000. The proceeds from the Private Placement will be used by the Company for payments to be made in connection with its previously announced acquisition of Empresa Minera Alcira SA.

 
New Pacific Closes Acquisition of Alcira, Change of Business, and Announces Name and Ticker Symbol Change

2017-07-20 marketwired
New Pacific Holdings Corp. ("New Pacific" or the "Company") (TSX VENTURE:NUX) announces that its wholly-owned subsidiary New Pacific Investment Corp. Limited has closed its previously announced acquisition (the "Acquisition") of Empresa Minera Alcira S.A., a private Bolivian incorporated mining company ("Alcira") from its three shareholders (the "Vendors") pursuant to the terms of a share purchase agreement (the "Agreement") dated March 28, 2017.

 
New Pacific Provides Update on Transaction to Acquire 100% of A Private Bolivian Mining Company

2017-06-07 marketwired
New Pacific Holdings Corp. ("New Pacific" or the "Company") (TSX VENTURE:NUX) today provided an update on its plans to acquire 100% of a private Bolivian mining company. The Company on April 10, 2017 announced it had signed a binding share purchase agreement dated March 28, 2017 (the "Agreement") to acquire a 100% interest in Empresa Minera Alcira S.A., ("Alcira"). As per the Agreement, the Company has been actively carrying out a confirmation drilling program in Bolivia to twin three drill holes drilled by Alcira in the past on its Silver Sand property.

 
New Pacific Reports Financial Results for the Three and Nine Months Ended March 31, 2017

2017-05-12 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 12, 2017) - New Pacific Holdings Corp. ("New Pacific" or the "Company") (TSX VENTURE:NUX) today announced its unaudited condensed consolidated interim financial results for the three and nine months ended March 31, 2017.

 
New Pacific Applies to List on TSX Venture Exchange as Investment Issuer and Voluntarily Delist from the Toronto Stock Exchange

2016-06-13 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 13, 2016) - New Pacific Metals Corp. (TSX:NUX) ("New Pacific" or the "Company") announces that it has applied to voluntarily delist its common shares (the "Common Shares") from the Toronto Stock Exchange (the "TSX") and has received conditional approval to list the Common Shares on the TSX Venture Exchange (the "TSX-V"). It is expected that the Common Shares will be delisted from the TSX on or about June 30, 2016, and listed on the TSX-V on or about the same date.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...